Deletion of phosphodiesterase 4D in mice shortens α2-adrenoceptor–mediated anesthesia, a behavioral correlate of emesis-Reference-Cited by-同舟云学术

Deletion of phosphodiesterase 4D in mice shortens α2-adrenoceptor–mediated anesthesia, a behavioral correlate of emesis

Published:2002-10-01 Issue:7 Volume:110 Page:1045-1052
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Robichaud Annette,Stamatiou Panagiota B.,Jin S.-L.Catherine,Lachance Nicholas,MacDonald Dwight,Laliberté France,Liu Susana,Huang Zheng,Conti Marco,Chan Chi-Chung

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference39 articles.

1. Cilomilast: a second generation phosphodiesterase 4 inhibitor for asthma and chronic obstructive pulmonary disease

2. Cyclic nucleotide phosphodiesterases

3. The New Phosphodiesterase 4 Inhibitor Roflumilast Is Efficacious in Exercise-Induced Asthma and Leads to Suppression of LPS-Stimulated TNF-α Ex Vivo

4. ArifloTM(SB 207499), a Second Generation Phosphodiesterase 4 Inhibitor for the Treatment of Asthma and COPD: from Concept to Clinic

Cited by 222 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phosphodiesterase 4 is overexpressed in human keloids and its inhibition reduces fibroblast activation and skin fibrosis;Chemico-Biological Interactions;2024-10

2. Beyond PDE4 inhibition: A comprehensive review on downstream cAMP signaling in the central nervous system;Biomedicine & Pharmacotherapy;2024-08

3. PDE4D: A Multipurpose Pharmacological Target;International Journal of Molecular Sciences;2024-07-24

4. A novel phosphodiesterase inhibitor for the treatment of chronic liver injury and metabolic diseases;Hepatology;2024-07-01

5. Therapeutic perspectives on PDE4B inhibition in adipose tissue dysfunction and chronic liver injury;Expert Opinion on Therapeutic Targets;2024-06-19